# Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery

> **NCT00211653** · PHASE1,PHASE2 · COMPLETED · sponsor: **Minneapolis Veterans Affairs Medical Center** · enrollment: 102 (actual)

## Conditions studied

- Kidney Failure

## Interventions

- **DRUG:** N-Acetylcysteine

## Key facts

- **NCT ID:** NCT00211653
- **Lead sponsor:** Minneapolis Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2007-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211653, "Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00211653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*